Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

25.60
Delayed Data
As of Jul 22
 +0.19 / +0.75%
Today’s Change
23.85
Today|||52-Week Range
43.63
-40.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line997.0K3.9M9.2M-520.0K
 
 
 
 
 
Depreciation3.8M3.7M3.9M3.9M
 
 
 
 
 
Total Other Cash Flow12.8M-7.0M15.2M6.8M
 
 
 
 
 
Funds From Operations18.7M18.4M15.4M26.0K
 
 
 
 
 
Funds From/For Other Operating Expenses15.7M-3.9M-6.9M-829.0K
 
 
 
 
 
Net Cash Flow - Operating Activities3.1M22.3M22.3M855.0K
 
 
 
 
 
 
InvestingIncrease In Investments-106.4M-84.0M-74.7M-40.2M
 
 
 
 
 
Decrease In Investments118.3M75.0M107.0M240.0M
 
 
 
 
 
Capital Expenditures-1.5M-968.0K-896.0K-1.0M
 
 
 
 
 
Net Cash Flow Investing9.9M-10.2M31.0M198.3M
 
 
 
 
 
 
FinancingShort Term Borrowings-149.0K66.0K--0.00
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-15.0K-90.0K-286.0K0.00
 
 
 
 
Net Proceeds Stock Sale1.5M1.7M10.1M73.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00194.0K0.00
 
 
Other Uses - Financing0.000.000.0025.0K
 
 
Net Cash Flow - Financing1.4M1.7M10.1M73.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash14.3M13.9M63.5M272.4M